The TFDA's updated labeling requirements, effective June 2026, represent one of the more significant compliance updates for foreign manufacturers selling into the Thai market in recent years. The changes affect labeling content, language requirements, and digital verification elements across multiple product categories. Foreign manufacturers with products already registered with the TFDA should treat this as a priority review item now, not after the effective date.
What Has Changed
Thai language requirements have been updated and tightened. The revisions specify minimum standards for Thai text content and positioning, mandatory Thai-language elements that were previously acceptable in English only, and expanded digital verification requirements extended to additional product categories. For medical devices specifically, UDI elements are being phased in alongside the new labeling requirements, creating alignment work for manufacturers approaching registration renewals or new submissions.
The TFDA's e-label verification system requirements are also expanding. For affected product categories, QR codes must link to TFDA-verified product information rather than simply manufacturer-hosted content. This is an operational workflow requirement that needs to be built into labeling processes and verified with your Thai regulatory partner before artwork is finalized.
Why This Matters More Than It Appears
Foreign manufacturers who register products with the TFDA are responsible for ensuring their product labels comply with Thai requirements at all times. Non-compliant labeling can result in import holds, product withdrawal requests, and complications at license renewal. This responsibility does not transfer to Thai importers or distributors, who frequently assume otherwise and may not flag labeling compliance issues until they create a commercial problem.
The practical complication for most foreign manufacturers is lead time. Artwork revisions require regulatory review of the proposed changes, translation review by a qualified Thai linguist, new artwork proofs, and in some cases TFDA submission for review before updated packaging can be manufactured. This process realistically takes 3 to 5 months end-to-end. Manufacturers who are not already in process face a real risk of being unable to source compliant packaging stock before the June effective date, which means either delaying new shipments or seeking a grace period from their Thai importer.
What You Should Do Now
The first step is a gap assessment of your current Thai-market labels against the June 2026 requirements. If you have not received formal guidance from your Thai regulatory partner about these changes, that is itself a concern worth investigating directly. The second step is engaging your regulatory affairs resource for Thailand to manage the artwork revision and, where required, TFDA submission process before the effective date. DeeMED Consulting manages Thai regulatory affairs for foreign manufacturers across pharmaceutical, medical device, and health product categories, including label compliance gap assessments and TFDA submissions.
Sources & Further Reading
- TFDA official notifications and labeling guidelines — www.fda.moph.go.th
- Pacific Bridge Medical, Thailand Pharmaceutical Registration Overview